Matuszewski Jason
Reporting owner on Forms 3, 4 and 5, CIK 1634730.
Matuszewski Jason reported on 1 issuer in 3 filings, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| BSEM · BioStem Technologies, Inc.CIK 1658678 | director, officer (Chief Executive Officer), 10% owner | 2 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| BSEM · BioStem Technologies, Inc.Common Stock | 2026-11-17 | S sold | -14,300 | $1 | 1,539,251 | Form 4 |
| BSEM · BioStem Technologies, Inc.Series A-1 Convertible Preferred Shares, derivative, holding | 100 | Form 4 | ||||
| BSEM · BioStem Technologies, Inc.Options (Right to Buy), derivative, holding | 2,000,000 | Form 4 | ||||
| BSEM · BioStem Technologies, Inc.Options (Right to Buy), derivative, holding | 198,807 | Form 4 | ||||
| BSEM · BioStem Technologies, Inc.Options (Right to Buy), derivative, holding | 40,427 | Form 4 | ||||
| BSEM · BioStem Technologies, Inc.Options (Right to Buy), derivative, holding | 440,529 | Form 4 | ||||
| BSEM · BioStem Technologies, Inc.Restricted Stock Units, derivative, holding | 33,874 | Form 4 | ||||
| BSEM · BioStem Technologies, Inc.Restricted Stock Units, derivative, holding | 99,901 | Form 4 | ||||
| BSEM · BioStem Technologies, Inc.Restricted Stock Units, derivative, holding | 363,636 | Form 4 | ||||
| BioStem Technologies, Inc. Common Stock | 2026-10-07 | M exercised | +250,000 | $2 | 1,553,551 | Form 4 |
| BioStem Technologies, Inc. Options (Right to Buy), derivative | 2026-10-07 | M exercised | -250,000 | $0 | 2,000,000 | Form 4 |
| BioStem Technologies, Inc. Series A-1 Convertible Preferred Shares, derivative, holding | 100 | Form 4 | ||||
| BioStem Technologies, Inc. Options (Right to Buy), derivative, holding | 198,807 | Form 4 | ||||
| BioStem Technologies, Inc. Options (Right to Buy), derivative, holding | 40,427 | Form 4 | ||||
| BioStem Technologies, Inc. Options (Right to Buy), derivative, holding | 440,529 | Form 4 | ||||
| BioStem Technologies, Inc. Restricted Stock Units, derivative, holding | 33,874 | Form 4 | ||||
| BioStem Technologies, Inc. Restricted Stock Units, derivative, holding | 99,901 | Form 4 | ||||
| BioStem Technologies, Inc. Restricted Stock Units, derivative, holding | 363,636 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-468654 | BioStem Technologies, Inc. | 2026-11-19 | ||
| 13G 0001213900-26-118035 | BSEM | 2026-11-10 | ||
| Form 4 0001193125-26-419152 | BioStem Technologies, Inc. | 2026-10-09 |